Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,399 | 4,510 | 8,364 | 13,291 | 21,537 |
| Marketable Securities | 33 | 33 | 33 | 33 | 32 |
| TOTAL | $21,458 | $9,510 | $13,647 | $18,912 | $24,511 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $21,458 | $9,510 | $13,647 | $18,912 | $24,511 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,212 | 2,780 | 1,200 | 1,738 | 1,575 |
| Accrued Expenses | 8,000 | 7,044 | 2,856 | 481 | 1,060 |
| TOTAL | $12,211 | $9,824 | $4,056 | $2,218 | $2,635 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 60 | 68 | 119 | 205 | 14,602 |
| TOTAL | $60 | $68 | $119 | $205 | $14,602 |
| Total Liabilities | $12,271 | $9,892 | $4,175 | $2,423 | $17,237 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,152 | 2,072 | 1,308 | 1,308 | 1,308 |
| Retained earnings | -119,732 | -108,152 | -98,035 | -90,687 | -90,449 |
| Other shareholders' equity | -371 | -371 | -371 | -371 | -371 |
| TOTAL | $9,187 | $-383 | $9,472 | $16,488 | $7,273 |
| Total Liabilities And Equity | $21,458 | $9,510 | $13,647 | $18,912 | $24,511 |